---
title: CMDE Releases Key Guidelines for Clinical Evaluation of Medical Devices
description: The CMDE issued a Notice outlining the recommended path for clinical evaluation of medical devices.
image: https://blog.arazygroup.com/hubfs/China-1.jpg
---

Open main menu Close main menu

- [Join The Regulatory Rockstar Movement](https://info.arazygroup.com/regulatory_rockstar_movement)

[Regulatory Affairs](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-affairs) [Regulatory Update](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-update)

# CMDE Releases Key Guidelines for Clinical Evaluation of Medical Devices

[Arazy Group](https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group)

[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.arazygroup.com/regulatory-affairs-advance/cmde-releases-key-guidelines-for-clinical-evaluation-of-medical-devices) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.arazygroup.com/regulatory-affairs-advance/cmde-releases-key-guidelines-for-clinical-evaluation-of-medical-devices) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.arazygroup.com/regulatory-affairs-advance/cmde-releases-key-guidelines-for-clinical-evaluation-of-medical-devices)

![](https://blog.arazygroup.com/hubfs/China-1.jpg)

On March 18, 2024, the Center for Medical Device Evaluation (CMDE) released an important Notice that highlights the recommended approach for the clinical evaluation of products in alignment with the Medical Device Classification Catalog (2024 Supplement) (No. 11, 2024). This announcement marks a significant milestone in ensuring the safety and efficacy of medical devices in the market.

The Notice comprises two essential document attachments:

1. The first attachment provides detailed instructions for leveraging the recommended pathway for clinical evaluation of related products within the "Classification Catalogue of Medical Devices" (2024 Supplement). This comprehensive guide offers insights into the regulatory framework and procedural steps necessary for conducting thorough clinical assessments.
2. The second document attachment focuses exclusively on the recommended path for clinical evaluation of related products within the same catalog. This targeted resource delves deeper into specific criteria and considerations pertinent to the evaluation process, facilitating a more nuanced understanding for stakeholders involved in the medical device industry.

For those seeking further information, the complete Notice and document attachments can be accessed via the CMDE website [here](https://www.cmde.org.cn/xwdt/shpgzgg/gztg/20240318132740198.html). (Available in English)

CMDE's proactive efforts in providing clear guidelines for clinical evaluation show their commitment to upholding rigorous standards in the medical device sector. By equipping stakeholders with valuable resources and insights, CMDE plays a pivotal role in fostering innovation while safeguarding patient health and well-being.

## Related Articles

[![](https://blog.arazygroup.com/hubfs/The%20Value%20of%20Expert%20Knowledge%20in%20the%20Age%20of%20AI.jpg)](https://blog.arazygroup.com/regulatory-affairs-advance/the-value-of-expert-knowledge-at-the-age-of-ai)

[Regulatory Affairs](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-affairs) [Regulatory Rockstar](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-rockstar) [Arazy Group](https://blog.arazygroup.com/regulatory-affairs-advance/tag/arazy-group)

### [Beyond Knowledge Toward Wisdom](https://blog.arazygroup.com/regulatory-affairs-advance/the-value-of-expert-knowledge-at-the-age-of-ai)

*Case Study: Regulatory Affairs in MedTech*

[Benjamin Arazy](https://blog.arazygroup.com/regulatory-affairs-advance/author/benjamin-arazy) 

[Read More](https://blog.arazygroup.com/regulatory-affairs-advance/the-value-of-expert-knowledge-at-the-age-of-ai)

[![](https://blog.arazygroup.com/hubfs/Mastering-Regulatory-Compliance-Insights-from-Singapores-Good-Submission-Practice-Workshop-2024-Arazy-Group.png)](https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-singapore)

[Regulatory Affairs](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-affairs) [Regulatory Update](https://blog.arazygroup.com/regulatory-affairs-advance/tag/regulatory-update)

### [Regulatory Update: Singapore](https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-singapore)

# Mastering Regulatory Compliance: Insights from Singapore’s Good Submission Practice Workshop 2024

Singapore’s Health Sciences Authority (HSA) remains at the forefront...

[Arazy Group](https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group) 

[Read More](https://blog.arazygroup.com/regulatory-affairs-advance/regulatory-update-singapore)

[Follow us on Facebook](https://www.facebook.com/Arazygroup/) [Follow us on LinkedIn](https://www.linkedin.com/company/arazy-group) [Follow us on Instagram](https://www.instagram.com/arazy_group/)

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Arazy Group",
    "url" : "https://blog.arazygroup.com/regulatory-affairs-advance/author/arazy-group"
  },
  "dateModified" : "2024-06-21T18:38:26.666Z",
  "datePublished" : "2024-05-13T17:57:19.000Z",
  "headline" : "CMDE Releases Key Guidelines for Clinical Evaluation of Medical Devices",
  "image" : [ "https://blog.arazygroup.com/hubfs/China-1.jpg" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.arazygroup.com/regulatory-affairs-advance/cmde-releases-key-guidelines-for-clinical-evaluation-of-medical-devices",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.arazygroup.com/hubfs/Arazy%20Group%20Logos%201.png"
    },
    "name" : "Arazy Group Consultants Inc."
  }
}
```